Castle Biosciences Inc. (CSTL) Tops Q3 EPS by 50c

Castle Biosciences Inc. (NASDAQ: CSTL) reported Q3 EPS of ($0.02), $0.50 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $83 million versus the consensus estimate of $71.03 million.

For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.

You May Also Be Interested In

• BofA says convenience store sales trail broader retail channels
• Lowe's Cos. (LOW) call put ratio 1.7 calls to 1 put into quarter results
• Taylor Devices (TAYD) Misses Q4 EPS by 31c